Celcuity LLC (CELC) Stock Analysis

Celcuity LLC (CELC) is a publicly traded company in the HEALTHCARE sector. It trades at $91.42, carries a market capitalization of $6.00B. This page summarizes the public market data, fundamentals, and frequently asked questions for CELC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $91.42
• Market Cap: $6.00B
• EPS: $-3.90
• 52-Week High: $151.02
• 52-Week Low: $11.28

Market Sentiment

Celcuity LLC currently has a Neutral sentiment score of 0.10.

About Celcuity LLC

Celcuity LLC is a pioneering clinical-stage biotechnology company headquartered in Minneapolis, Minnesota, dedicated to transforming cancer treatment through its cutting-edge approach to cancer subtype identification and targeted therapies. Leveraging its proprietary Celcuity technology platform, the company focuses on uncovering specific biological markers in cancer patients, facilitating personalized and effective treatment options. With a promising pipeline of drug candidates and a strong ...

GNG Research Analysis

GNG Research scores Celcuity LLC (CELC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CELC.

Frequently Asked Questions

Does CELC pay dividends?

Celcuity LLC (CELC) does not currently pay a regular dividend.

What is CELC's market cap?

Celcuity LLC (CELC) has a market capitalization of $6.00B with a current stock price of $91.42.